Regulus Therapeutics (STU:7RG0) YoY EPS Growth : 31.89% (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Regulus Therapeutics YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Regulus Therapeutics's YoY EPS Growth for the quarter that ended in Mar. 2024 was 31.89%.

Regulus Therapeutics's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was €-0.27.

Regulus Therapeutics YoY EPS Growth Historical Data

The historical data trend for Regulus Therapeutics's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regulus Therapeutics YoY EPS Growth Chart

Regulus Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EPS Growth

Get a 7-Day Free Trial

80.22

61.94

22.49

38.75

17.48

Regulus Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EPS Growth	Get a 7-Day Free Trial															6.22	27.70	25.74	5.29	31.89

Regulus Therapeutics YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Regulus Therapeutics's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EPS Growth (A: Dec. 2023 )
=	(Earnings per Share (Diluted) (A: Dec. 2023 )	-	Earnings per Share (Diluted) (A: Dec. 2022 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2022 ) \|
=	(-1.449	-	-1.756)	/	\| -1.756 \|
=	17.48 %

Regulus Therapeutics's YoY EPS Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EPS Growth (Q: Mar. 2024 )
=	(Earnings per Share (Diluted) (Q: Mar. 2024 )	-	Earnings per Share (Diluted) (Q: Mar. 2023 ))	/	\| Earnings per Share (Diluted) (Q: Mar. 2023 )) \|
=	(-0.267	-	-0.392)	/	\| -0.392 \|
=	31.89 %

Regulus Therapeutics YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Regulus Therapeutics's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Regulus Therapeutics (STU:7RG0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regulus Therapeutics Inc (STU:7RG0) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

RGLS:USA

Address

4224 Campus Point Court, Suite 210, San Diego, CA, USA, 92121

Website

https://www.regulusrx.com

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The company partnered with Sanofi to create a compound targeting orphan diseases and with AstraZeneca to cure Type 2 Diabetes/prediabetes.

Regulus Therapeutics (STU:7RG0) Headlines

No Headlines